奥西默替尼
小RNA
腺癌
微阵列
微阵列分析技术
计算生物学
肺
生物
生物信息学
癌症研究
医学
基因
遗传学
基因表达
内科学
癌症
ROS1型
作者
Fen Liu,Xiyan Wang,Wenjun Tian,Xueli Dong,Guanghai Wang
标识
DOI:10.1615/jenvironpatholtoxicoloncol.2024054531
摘要
<b>Background: </b>This study was to screen for circRNAs associated with osimertinib resistance in lung adenocarcinoma (LUAD) and establish a circRNA-miRNA-mRNA ceRNA network. <b>Methods:</b> DESeq2 analysis was used to identify circRNAs in GEO database associated with osimertinib resistance in LUAD. Differentially expressed miRNAs in LUAD intersected with the target miRNAs of circRNA. Predicted target gene for miRNAs were overlapped with the co-expressed genes of EGFR. Hsa_circ_0078465/miR-183-5p/NRAS axis was validated in cells. <b>Results:</b> Osimertinib resistance-related circRNAs in LUAD were linked to six differentially expressed miRNAs and 35 EGFR-related mRNAs. NRAS was the hub gene. These mRNAs were associated with cell motility regulation, non-small cell lung cancer and EGFR tyrosine kinase inhibitor resistance pathway. The cell proliferation and migration assays confirmed the promoting role of hsa_circ_0078465/miR-183-5p/NRAS axis in osimertinib-resistant cells. <b>Conclusion:</b> A circRNA-miRNA-mRNA network associated with osimertinib resistance in LUAD proposed hsa_ circ_0078465/miR-183-5p/NRAS axis.
科研通智能强力驱动
Strongly Powered by AbleSci AI